home / stock / pepg / pepg news

PEPG News and Press, PepGen Inc. From 05/14/24

Stock Information
Company Name: PepGen Inc.
Stock Symbol: PEPG
Market: NASDAQ
Website: pepgen.com
Menu
PEPG PEPG Quote PEPG Short PEPG News PEPG Articles PEPG Message Board
Get PEPG Alerts

News, Short Squeeze, Breakout and More Instantly...
PEPG - PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

– CONNECT1-EDO51 trial preliminary data from 5mg/kg dose cohort expected mid-2024 – – FREEDOM1-DM1 trial preliminary data from at least 5mg/kg dose cohort expected second half 2024 – – N et proceeds of $86.3 million from common ...
PEPG - HHS panel to vote in Nov. on DMD screening for newborns

2024-05-09 18:44:45 ET More on Catalyst Pharmaceuticals, Sarepta Therapeutics, etc. Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics: Growth Trajectory Alter...

PEPG - Trading (PEPG) With Integrated Risk Controls

2024-05-06 13:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PEPG - Edgewise gets EU orphan drug status for muscular dystrophy drug

2024-04-23 10:29:06 ET More on Edgewise Therapeutics Edgewise Therapeutics: Behind The Massive Rally Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Edgewise Therapeutics Historical earnings data for Edg...
PEPG - Learn to Evaluate (PEPG) using the Charts

2024-04-16 23:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PEPG - PepGen to Participate in Upcoming Investor Conferences

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management w...

PEPG - PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that the U.S. Foo...
PEPG - Berkshire Hills Bancorp, Inc. declares $0.18 dividend

2024-03-07 17:20:30 ET More on etc. Associated Banc-Corp: Don't Bank On More Massive Upside (Rating Downgrade) PepGen, Inc. (PEPG) Q4 2023 Earnings Call Transcript FRP Holdings, Inc. (FRPH) Q4 2023 Earnings Call Transcript Funko announces resignation of Steve...

PEPG - PepGen, Inc. (PEPG) Q4 2023 Earnings Call Transcript

2024-03-07 17:10:33 ET PepGen, Inc. (PEPG) Q4 2023 Earnings Conference Call March 06, 2024, 04:30 PM ET Company Participants Emiko Bryant - Chief of Staff James McArthur - President and CEO Michelle Mellion - SVP and Head, Clinical Development Noel Donnelly -...

PEPG - PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments

- Enrollment completed for PGN-EDO51 5 mg/kg cohort in CONNECT1-EDO51 Phase 2 clinical trial in DMD patients. The Company expects to announce preliminary data from the 5 mg/kg dose cohort in mid-2024 – - CONNECT2-EDO51 Phase 2 clinical trial in DMD patients open in the U.K. - Com...
Previous 10 Next 10